HRP980105A2 - Pharmaceutical formulations containing poorly soluble drug substances - Google Patents

Pharmaceutical formulations containing poorly soluble drug substances

Info

Publication number
HRP980105A2
HRP980105A2 HR980105A HRP980105A HRP980105A2 HR P980105 A2 HRP980105 A2 HR P980105A2 HR 980105 A HR980105 A HR 980105A HR P980105 A HRP980105 A HR P980105A HR P980105 A2 HRP980105 A2 HR P980105A2
Authority
HR
Croatia
Prior art keywords
agents
pharmaceutical formulation
medicinal substance
drug
solution
Prior art date
Application number
HR980105A
Other languages
English (en)
Croatian (hr)
Inventor
Nancy M Franson
Original Assignee
Nancy M. Franson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/808,761 external-priority patent/US5760056A/en
Priority claimed from US08/813,946 external-priority patent/US5837714A/en
Priority claimed from US08/810,560 external-priority patent/US5776987A/en
Application filed by Nancy M. Franson filed Critical Nancy M. Franson
Publication of HRP980105A2 publication Critical patent/HRP980105A2/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR980105A 1997-03-03 1998-03-02 Pharmaceutical formulations containing poorly soluble drug substances HRP980105A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/808,761 US5760056A (en) 1997-03-03 1997-03-03 Pharmaceutical formulation
US08/813,946 US5837714A (en) 1997-03-03 1997-03-03 Solid pharmaceutical dispersions
US08/810,560 US5776987A (en) 1997-03-03 1997-03-03 Pharmaceutical suspension formulation
US2850498A 1998-02-24 1998-02-24

Publications (1)

Publication Number Publication Date
HRP980105A2 true HRP980105A2 (en) 1999-02-28

Family

ID=27487679

Family Applications (1)

Application Number Title Priority Date Filing Date
HR980105A HRP980105A2 (en) 1997-03-03 1998-03-02 Pharmaceutical formulations containing poorly soluble drug substances

Country Status (10)

Country Link
EP (1) EP0996436B1 (fr)
JP (2) JP4510156B2 (fr)
AT (1) ATE300293T1 (fr)
BR (1) BR9808136A (fr)
CA (1) CA2281946C (fr)
DE (1) DE69830997T2 (fr)
ES (1) ES2242273T3 (fr)
HR (1) HRP980105A2 (fr)
NO (1) NO325726B1 (fr)
WO (1) WO1998038987A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197787B1 (en) * 1997-03-03 2001-03-06 Sanofi-Synthelabo Pharmaceutical formulations containing poorly soluble drug substances
US6342249B1 (en) 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
KR100618234B1 (ko) * 1998-12-23 2006-09-01 알자 코포레이션 다공성 입자를 포함하는 제형
US6387400B1 (en) * 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations
MX2010010202A (es) * 2008-03-21 2010-12-21 Smart Salt Inc Sales comestibles tipo carnalita y productos de las mismas.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE12072T1 (de) * 1981-09-25 1985-03-15 Lacer Sa 1-azaxanthon zur therapeutischen verwendung, verfahren zu seiner herstellung und pharmazeutische zusammensetzungen.
US4725427A (en) * 1984-03-13 1988-02-16 Albion International, Inc. Effervescent vitamin-mineral granule preparation
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
DD293499A5 (de) * 1989-06-06 1991-09-05 Arzneimittelwerk Dresden Gmbh,De Verfahren zur herstellung cyclosporinhaltiger galenischer formulierungen
FR2665898B1 (fr) * 1990-08-20 1994-03-11 Sanofi Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
FI933044A7 (fi) * 1991-11-04 1993-09-02 Fuisz Technologies Ltd Vesiliukoinen jakelujärjestelmä hydrofobisia nesteitä varten
JP3121080B2 (ja) * 1991-12-19 2000-12-25 アール・ピー・シーラー コーポレイション カプセル封入用溶液
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
GB9302720D0 (en) * 1993-02-11 1993-03-24 Scherer Ltd R P Products in capsule form for use in aqueous solution

Also Published As

Publication number Publication date
BR9808136A (pt) 2000-03-28
CA2281946C (fr) 2007-08-07
WO1998038987A1 (fr) 1998-09-11
NO994249L (no) 1999-11-03
ATE300293T1 (de) 2005-08-15
JP4510156B2 (ja) 2010-07-21
EP0996436B1 (fr) 2005-07-27
JP2009286798A (ja) 2009-12-10
JP2002513406A (ja) 2002-05-08
DE69830997D1 (de) 2005-09-01
CA2281946A1 (fr) 1998-09-11
EP0996436A4 (fr) 2001-04-11
EP0996436A1 (fr) 2000-05-03
NO994249D0 (no) 1999-09-02
DE69830997T2 (de) 2006-02-09
JP5563260B2 (ja) 2014-07-30
ES2242273T3 (es) 2005-11-01
NO325726B1 (no) 2008-07-07

Similar Documents

Publication Publication Date Title
EP1185273B1 (fr) Composition antifongique destinee a etre administree par voie orale contenant de l'itraconazole et procede de preparation correspondant
EP1175205B1 (fr) Dispersion solide comrpenant ritonavir, fenofibrate ou griseofulvin
US6197787B1 (en) Pharmaceutical formulations containing poorly soluble drug substances
FI96274B (fi) Menetelmä valmistaa pimobendaanin oraalisia lääkeainemuotoja
EP1207872B1 (fr) Gels mous contenant de l'ibuprofene
JPH0667829B2 (ja) イブプロフエン含有ゼラチン軟カプセルおよびその製造方法
EA023433B1 (ru) Фармацевтическая композиция ингибитора протеазы вируса гепатита c
CA2374117A1 (fr) Formulations comprenant des agents regulateurs des lipides
JP5563260B2 (ja) 難溶性薬剤物質を含有する医薬製剤
MX2007012124A (es) Formulaciones mejoradas de fenofibrato.
KR890000182B1 (ko) 액상 윤활제-함유 약제학적 조성물 및 약제학적 제형의 용해도 개선방법
WO2014167579A2 (fr) Compositions pharmaceutiques stables de tadalafil
KR20070113289A (ko) 멘톨 또는 ｐｅｇ/폴록사머를 함유하는 개선된페노피브레이트 제제
JP2001523718A (ja) 溶存パロキセチンを含む処方
Lee et al. Effect of poloxamer on the dissolution of felodipine and preparation of controlled release matrix tablets containing felodipine
EP0449426B1 (fr) Composition pharmaceutique
US5837714A (en) Solid pharmaceutical dispersions
WO1998047499A1 (fr) Preparations a base de flutamide et leurs procedes de preparation
MXPA99008054A (en) Pharmaceutical formulations containing poorly soluble drug substances
DK169566B1 (da) Flydende farmaceutisk præparat indeholdende en 4-aroyl-imidazol-2-on til anvendelse i doseringsformer til oral indgivelse samt fremgangsmåde til fremstilling af præparatet
JP2003277262A (ja) ランソプラゾールのバイオアベイラビリティ改善技術
WO2023088976A1 (fr) Compositions de lévothyroxine orodispersible
KR20250052834A (ko) 프란루카스트의 생체이용률이 개선된 약제학적 조성물 및 그 제조방법
CA2433553A1 (fr) Compositions pharmaceutiques incluant du sampatrilat disperse dans un excipient lipidique

Legal Events

Date Code Title Description
ODRP Renewal fee for the maintenance of a patent

Payment date: 19980302

Year of fee payment: 1

A1OB Publication of a patent application
OBST Application withdrawn